copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - Æxlishemjandi lyf - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.
omnic hart hylki með breyttan losunarhraða 0,4 mg
astellas pharma a/s* - tamsulosinum hýdróklóríð - hart hylki með breyttan losunarhraða - 0,4 mg
sporanox hart hylki 100 mg
janssen-cilag ab - itraconazolum inn - hart hylki - 100 mg
ramíl tafla 5 mg
teva b.v.* - ramiprilum inn - tafla - 5 mg
ramíl tafla 2,5 mg
teva b.v.* - ramiprilum inn - tafla - 2,5 mg
ramíl tafla 10 mg
teva b.v.* - ramiprilum inn - tafla - 10 mg
tadalafil krka filmuhúðuð tafla 10 mg
krka, d.d., novo mesto - tadalafilum inn - filmuhúðuð tafla - 10 mg
tadalafil krka filmuhúðuð tafla 20 mg
krka, d.d., novo mesto - tadalafilum inn - filmuhúðuð tafla - 20 mg
tadalafil krka filmuhúðuð tafla 5 mg
krka, d.d., novo mesto - tadalafilum inn - filmuhúðuð tafla - 5 mg